Circulating miR-1, miR-133a, and miR-206 levels are increased after a half-marathon run

Biomarkers

Volumn 19, Issue 7, 2014, Pages 585-589

  Gomes, Clarissa P C ^a   Oliveira Jr, Getúlio P ^b   Madrid, Bibiano ^a   Almeida, Jeeser A ^a   Franco, Octávio L ^a,b   Pereira, Rinaldo W ^a,b  

^a UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Exercise; Extracellular vesicles; MicroRNA; Plasma; Quantitative PCR

Indexed keywords

COMPLEMENTARY DNA; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 206; UNCLASSIFIED DRUG; GENETIC MARKER; MIRN1 MICRORNA, HUMAN; MIRN133 MICRORNA, HUMAN; MIRN206 MICRORNA, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; HUMAN; MALE; MARATHON RUNNER; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; ENDURANCE; GENETIC MARKER; GENETICS; REAL TIME POLYMERASE CHAIN REACTION; RUNNING; TIME; UPREGULATION;

ADULT; GENETIC MARKERS; HUMANS; MALE; MICRORNAS; PHYSICAL ENDURANCE; REAL-TIME POLYMERASE CHAIN REACTION; RUNNING; TIME FACTORS; UP-REGULATION;

EID: 84912037192     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.952663     Document Type: Article

References (52)

1. Adachi T, Nakanishi M, Otsuka Y, et al. (2010). Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 56:1183-5.
2. Ai J, Zhang R, Li Y, et al. (2010). Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 391:73-7.
3. Allen DL, Bandstra ER, Harrison BC, et al. (2009). Effects of spaceflight on murine skeletal muscle gene expression. J Appl Physiol 106:582-95.
4. Aoi W, Ichikawa H, Mune K, et al. (2013). Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men. Frontier Physiol 4:1-7.
5. Arroyo JD, Chevillet JR, Kroh EM, et al. (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108:5003-8.
6. Baggish AL, Hale A, Weiner RB, et al. (2011). Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol 589:3983-94.
7. Baggish AL, Park J, Min PK, et al. (2014). Rapid upregulation and clearance of distinct circulating microRNAs after prolonged aerobic exercise. J Appl Physiol 116:522-31.
8. Banzet S, Chennaoui M, Girard O, et al. (2013). Changes in circulating microRNAs levels with exercise modality. J Appl Physiol (1985) 115: 1237-44.
9. Bartel DP. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136:215-33.
10. Bustin SA, Benes V, Garson JA, et al. (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611-22.
11. Chen JF, Mandel EM, Thomson JM, et al. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nature Genet 38:228-33.
12. Cheng Y, Tan N, Yang J, et al. (2010). A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond) 119:87-95.
13. Corsten MF, Dennert R, Jochems S, et al. (2010). Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circulation: Cardiovasc Genet 3:499-506.
14. D'alessandra Y, Devanna P, Limana F, et al. (2010). Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31 2765-73.
15. Devaux Y, Vausort M, Goretti E, et al. (2012). Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem 58: 559-67.
16. Drummond MJ, Mccarthy JJ, Fry CS, et al. (2008). Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids. Am J Physiol Endocrinol Metabol 295:E1333-40.
17. Etheridge A, Gomes CPC, Pereira RW, et al. (2013). The complexity, function and applications of RNA in circulation. Front Genet 4:1-8.
18. Etheridge A, Lee I, Hood L, et al. (2011). Extracellular microRNA: a new source of biomarkers. Mutat Res 717:85-90.
19. Friedman RC, Farh KK, Burge CB, Bartel DP. (2009). Most mammalian mRNAs are conserved targets of microRNAs. Gen Res 19:92-105.
20. Gupta S, Knowlton AA. (2007). HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol. Heart Circ Physiol 292:H3052-6.
21. Hikida RS, Staron RS, Hagerman FC, et al. (1983). Muscle fiber necrosis associated with human marathon runners. J Neurol Sci 59:185-203.
22. Huang Z, Huang D, Ni S, et al. (2010). Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127:118-26.
23. Lagos-Quintana M, Rauhut R, Yalcin A, et al. (2002). Identification of tissue-specific microRNAs from mouse. Curr Biol 12:735-9.
24. Laterza OF, Lim L, Garrett-Engele PW, et al. (2009). Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55:1977-83.
25. Lee EJ, Baek M, Gusev Y, et al. (2008). Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA 14:35-42.
26. Lee RC, Feinbaum RL, Ambros V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-54.
27. Lewis BP, Burge CB, Bartel DP. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
28. Liu X, Liu L, Xu Q, et al. (2012). MicroRNA as a novel drug target for cancer therapy. Expert Opin Biol Therap 12:573-80.
29. Lotvall J, Valadi H. (2007). Cell to cell signalling via exosomes through esRNA. Cell Adhes Migration 1:156-8.
30. Marini M, Veicsteinas A. (2010). The exercised skeletal muscle: a review. Eur J Transl Myol-Myol Rev 20:105-20.
31. Mccarthy JJ, Esser KA. (2007). MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy. J Appl Physiol 102:306-13.
32. Mitchell PS, Parkin RK, Kroh EM, et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513-18.
33. Mizuno H, Nakamura A, Aoki Y, et al. (2011). Identification of musclespecific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS ONE 6:e18388.
34. Mooren FC, Viereck J, Kruger K, Thum T. (2014). Circulating micrornas as potential biomarkers of aerobic exercise capacity. Am J Physiol Heart Circ Physiol 306:H557-63.
35. Murray MY, Rushworth SA, Macewan DJ. (2012). Micro RNAs as a new therapeutic target towards leukaemia signalling. Cell Signal 24:363-8.
36. Nielsen S, Scheele C, Yfanti C, et al. (2010). Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. J Physiol 588:4029-37.
37. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, et al. (2010). Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 107:6328-33.
38. Schratt GM, Tuebing F, Nigh EA, et al. (2006). A brain-specific microRNA regulates dendritic spine development. Nature 439: 283-9.
39. Taylor DD, Gercel-Taylor C. (2008). MicroRNA signatures of tumorderived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110:13-21.
40. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. (2011). Characterization of extracellular circulating microRNA. Nucl Acid Res 39:7223-33.
41. Uhlemann M, Möbius-Winkler S, Fikenzer S, et al. (2014). Circulating microRNA-126 increases after different forms of endurance exercise in healthy adults. Eur J Prev Cardiol 21:484-91.
42. Valadi H, Ekstrom K, Bossios A, et al. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-9.
43. Van Rooij E, Olson EN. (2007). MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Investig 117: 2369-76.
44. Vickers KC, Palmisano BT, Shoucri BM, et al. (2011). MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13:423-33.
45. Vignier N, Amor F, Fogel P, et al. (2013). Distinctive serum miRNA profile in mouse models of striated muscular pathologies. PLoS One 8:e55281.
46. Wang GK, Zhu JQ, Zhang JT, et al. (2010a). Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31:659-66.
47. Wang K, Zhang S, Marzolf B, et al. (2009). Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106:4402-7.
48. Wang K, Zhang S, Weber J, et al. (2010b). Export of microRNAs and microRNA-protective protein by mammalian cells. Nucl Acid Res 38: 7248-59.
49. Wang R, Li N, Zhang Y, et al. (2011). Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Intern Med 50:1789-95.
50. Warhol MJ, Siegel AJ, Evans WJ, Silverman LM. (1985). Skeletal muscle injury and repair in marathon runners after competition. Am J Pathol 118:331-9.
51. Weber JA, Baxter DH, Zhang S, et al. (2010). The microRNA spectrum in 12 body fluids. Clin Chem 56:1733-41.
52. Zhao H, Shen J, Medico L, et al. (2010). A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 5:e13735.